Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Centre Antoine-Lacassagne

3 abstracts

Abstract
Efficacy of olaparib combined to metronomic cyclophosphamide and metformin in patients with recurrent advanced/metastatic endometrial by molecular subtypes: ENDOLA phase I/II trial.
Org: Gustave-Roussy Cancer Campus, Centre Antoine-Lacassagne, Pole Santé Publique, Pharmacie, URCC,
Abstract
Phase I/II study of pazopanib and temozolomide in patients with newly diagnosed and resected glioblastoma: PAZOGLIO trial.
Org: Centre Antoine-Lacassagne, University Côte d'Azur, ICO Cancer Center, Institut de Cancérologie de l’Ouest, CHU de Nice,
Abstract
Afatinib in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN) harboring alterations in the HER pathway: Results of the B1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM).
Org: Cliniques Universitaires Saint-Luc, Department of Drug Development and Innovation (D3i), Institut Curie, Saint Cloud, France, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy, University of Milano, European Institute of Oncology, Division of Early Drug Development,